SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-028762
Filing Date
2022-08-08
Accepted
2022-08-08 17:17:53
Documents
14
Period of Report
2022-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10040558_8k.htm   iXBRL 8-K 26508
2 EXHIBIT 99.1 brhc10040558_ex99-1.htm EX-99.1 98775
6 image00001.jpg GRAPHIC 4367
  Complete submission text file 0001140361-22-028762.txt   279888

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rckt-20220808.xsd EX-101.SCH 3877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20220808_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20220808_pre.xml EX-101.PRE 16052
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10040558_8k_htm.xml XML 4057
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 221145446
SIC: 2834 Pharmaceutical Preparations